Over 75% of clinical trial sites who have not yet adopted eRegulatory plan to do so in 2019.

Why? In addition to growing industry pressure from sponsors who expect a digital site infrastructure, trial sites with eRegulatory platforms are introducing key advantages over those sites without eReg.

What are those advantages?

Not a part of the Florence Family? Schedule a demo so we can show you why 4,500+ research sites are.

We would love to welcome you to the Florence Network of sites maximizing their efficiency with Florence eBinders. Let’s schedule a personal demo together so our team can show you why sites love us so much they’ve made us the #1 eRegulatory solution.